[1] 付小兵.构建一个创面治疗学科体系:中国特色创面治疗中心建设20年的回顾与展望[J]. 中华烧伤杂志,2018,34(12):859-863.
[2] MAIONE AG, SMITH A, KASHPUR O, et al. Altered ECM deposition by diabetic foot ulcer-derived fibroblasts implicates fibronectin in chronic wound repair. Wound Repair Regen. 2016;24(4):630-643.
[3] CATRINA SB, ZHENG X. Disturbed hypoxic responses as a pathogenic mechanism of diabetic foot ulcers. Diabetes Metab Res Rev. 2016;32 Suppl 1:179-185.
[4] GEIGER A, WALKER A, NISSEN E. Human fibrocyte-derived exosomes accelerate wound healing in genetically diabetic mice. Biochem Biophys Res Commun. 2015; 467(2):303-309.
[5] 盘艳君,王燕,徐健强,等.固醇调节元件结合蛋白与炎症的关系研究进展[J].生物化学与生物物理进展,2016,43(12):1146-1153.
[6] MOON YA. The SCAP/SREBP Pathway: A Mediator of Hepatic Steatosis. Endocrinol Metab (Seoul). 2017;32(1):6-10.
[7] 张强,许璨,唐朝克,等.细胞内胆固醇水平调节研究进展[J].生物化学与生物物理进展,2022,49(2):1-12.
[8] 周琦,孙慧娟,于栋华,等.巨噬细胞M1/M2型极化在不同疾病中的作用机制[J].中国药理学通报,2020,36(11):1502-1506.
[9] RATHINAM VA, FITZGERALD KA. Inflammasome Complexes: Emerging Mechanisms and Effector Functions. Cell. 2016;165(4):792-800.
[10] GEYEREGGER R, SHEHATA M, ZEYDA M, et al. Liver X receptors interfere with cytokine-induced proliferation and cell survival in normal and leukemic lymphocytes. J Leukoc Biol. 2009;86(5):1039-1048.
[11] KUSNADI A, PARK SH, YUAN R, et al. The Cytokine TNF Promotes Transcription Factor SREBP Activity and Binding to Inflammatory Genes to Activate Macrophages and Limit Tissue Repair. Immunity. 2019;51(2):241-257.e9.
[12] IM SS, YOUSEF L, BLASCHITZ C, et al. Linking lipid metabolism to the innate immune response in macrophages through sterol regulatory element binding protein-1a. Cell Metab. 2011;13(5):540-549.
[13] KIDANI Y, ELSAESSER H, HOCK MB, et al. Sterol regulatory element-binding proteins are essential for the metabolic programming of effector T cells and adaptive immunity. Nat Immunol. 2013;14(5):489-499.
[14] DANG EV, MCDONALD JG, RUSSELL DW, et al. Oxysterol Restraint of Cholesterol Synthesis Prevents AIM2 Inflammasome Activation. Cell. 2017;171(5):1057-1071.e11.
[15] 伍莎莎,欧阳南,何泉,等.胆固醇敏感器SCAP功能失调通过上调P2X7受体表达促进THP-1源性巨噬细胞炎症小体活化[J].第三军医大学学报,2017, 39(13):1327-1332.
[16] OUYANG N, GAN H, HE Q, et al. Dysfunction of cholesterol sensor SCAP promotes inflammation activation in THP-1 macrophages. Exp Cell Res. 2018;367(2):162-169.
[17] GUO C, CHI Z, JIANG D, et al. Cholesterol Homeostatic Regulator SCAP-SREBP2 Integrates NLRP3 Inflammasome Activation and Cholesterol Biosynthetic Signaling in Macrophages. Immunity. 2018;49(5):842-856.e7.
[18] SHEN HH, YANG YX, MENG X, et al. NLRP3: A promising therapeutic target for autoimmune diseases. Autoimmun Rev. 2018;17(7):694-702.
[19] DE LA ROCHE M, HAMILTON C, MORTENSEN R, et al. Trafficking of cholesterol to the ER is required for NLRP3 inflammasome activation. J Cell Biol. 2018;217(10):3560-3576.
[20] FRANCHI L, EIGENBROD T, MUÑOZ-PLANILLO R, et al. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol. 2009;10(3):241-247.
[21] RAUD B, MCGUIRE PJ, JONES RG, et al. Fatty acid metabolism in CD8+ T cell memory: Challenging current concepts. Immunol Rev. 2018;283(1):213-231.
[22] HU MS, WALMSLEY GG, BARNES LA, et al. Delivery of monocyte lineage cells in a biomimetic scaffold enhances tissue repair. JCI Insight. 2017;2(19):e96260.
[23] Reboldi A, Dang EV, McDonald JG, et al. Inflammation. 25-Hydroxycholesterol suppresses interleukin-1-driven inflammation downstream of type I interferon. Science. 2014;345(6197):679-684.
[24] VASANJI A, GHOSH PK, GRAHAM LM, et al. Polarization of plasma membrane microviscosity during endothelial cell migration. Dev Cell. 2004;6(1):29-41.
[25] GHOSH PK, VASANJI A, MURUGESAN G, et al. Membrane microviscosity regulates endothelial cell motility. Nat Cell Biol. 2002;4(11):894-900.
[26] ZHOU RH, YAO M, LEE TS, et al. Vascular endothelial growth factor activation of sterol regulatory element binding protein: a potential role in angiogenesis. Circ Res. 2004;95(5):471-478.
[27] LI A, DUBEY S, VARNEY ML, et al. IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol. 2003;170(6):3369-3376.
[28] YAO M, ZHOU RH, PETREACA M, et al. Activation of sterol regulatory element-binding proteins (SREBPs) is critical in IL-8-induced angiogenesis. J Leukoc Biol. 2006;80(3):608-620.
[29] YEH M, COLE AL, CHOI J, et al. Role for sterol regulatory element-binding protein in activation of endothelial cells by phospholipid oxidation products. Circ Res. 2004;95(8):780-788.
[30] BENGOECHEA-ALONSO MT, PUNGA T, ERICSSON J. Hyperphosphorylation regulates the activity of SREBP1 during mitosis. Proc Natl Acad Sci U S A. 2005; 102(33):11681-11686.
[31] BENGOECHEA-ALONSO MT, Ericsson J. Cdk1/cyclin B-mediated phosphorylation stabilizes SREBP1 during mitosis. Cell Cycle. 2006;5(15):1708-1718.
[32] INOUE N, SHIMANO H, NAKAKUKI M, et al. Lipid synthetic transcription factor SREBP-1a activates p21WAF1/CIP1, a universal cyclin-dependent kinase inhibitor. Mol Cell Biol. 2005;25(20):8938-8947.
[33] 庞晓文,张萍,刘雯,等.寻常型银屑病表皮中固醇调节元件结合蛋白-1表达模式的研究[J].中国麻风皮肤病杂志,2011,27(3):161-163.
[34] PARK SH, KANG K, GIANNOPOULOU E, et al. Type I interferons and the cytokine TNF cooperatively reprogram the macrophage epigenome to promote inflammatory activation. Nat Immunol. 2017;18(10):1104-1116.
[35] SEO YK, JEON TI, CHONG HK, et al. Genome-wide localization of SREBP-2 in hepatic chromatin predicts a role in autophagy. Cell Metab. 2011;13(4):367-375.
[36] BROWN MS, RADHAKRISHNAN A, GOLDSTEIN JL. Retrospective on Cholesterol Homeostasis: The Central Role of Scap. Annu Rev Biochem. 2018;87:783-807.
[37] ADAMS CM, REITZ J, DE BRABANDER JK, et al. Cholesterol and 25-hydroxycholesterol inhibit activation of SREBPs by different mechanisms, both involving SCAP and Insigs. J Biol Chem. 2004;279(50):52772-52780.
[38] KAMISUKI S, MAO Q, ABU-ELHEIGA L, et al. A small molecule that blocks fat synthesis by inhibiting the activation of SREBP. Chem Biol. 2009;16(8):882-892.
[39] SHAO W, MACHAMER CE, ESPENSHADE PJ. Fatostatin blocks ER exit of SCAP but inhibits cell growth in a SCAP-independent manner. J Lipid Res. 2016;57(8):1564-1573.
[40] MCRAE S, IQBAL J, SARKAR-DUTTA M, et al. Withdrawal: The hepatitis C virus-induced NLRP3 inflammasome activates the sterol regulatory element-binding protein (SREBP) and regulates lipid metabolism. J Biol Chem. 2018;293(52):20011.
[41] RAEDER MB, FERNØ J, GLAMBEK M, et al. Antidepressant drugs activate SREBP and up-regulate cholesterol and fatty acid biosynthesis in human glial cells. Neurosci Lett. 2006;395(3):185-190.
[42] COLGAN SM, TANG D, WERSTUCK GH, et al. Endoplasmic reticulum stress causes the activation of sterol regulatory element binding protein-2. Int J Biochem Cell Biol. 2007;39(10):1843-1851.
[43] LEE JN, YE J. Proteolytic activation of sterol regulatory element-binding protein induced by cellular stress through depletion of Insig-1. J Biol Chem. 2004;279(43):45257-45265.
[44] KOTZKA J, LEHR S, ROTH G, et al. Insulin-activated Erk-mitogen-activated protein kinases phosphorylate sterol regulatory element-binding Protein-2 at serine residues 432 and 455 in vivo. J Biol Chem. 2004;279(21):22404-22411.
[45] EID W, DAUNER K, COURTNEY KC, et al. mTORC1 activates SREBP-2 by suppressing cholesterol trafficking to lysosomes in mammalian cells. Proc Natl Acad Sci U S A. 2017;114(30):7999-8004.
[46] FUHRMAN B, NITZAN O, KARRY R, et al. Urokinase plasminogen activator (uPA) stimulates cholesterol biosynthesis in macrophages through activation of SREBP-1 in a PI3-kinase and MEK-dependent manner. Atherosclerosis. 2007;195(2):e108-e116.
[47] WALKER AK, JACOBS RL, WATTS JL, et al. A conserved SREBP-1/phosphatidylcholine feedback circuit regulates lipogenesis in metazoans. Cell. 2011;147(4):840-852.
[48] KANG OH, KIM SB, MUN SH, et al. Puerarin ameliorates hepatic steatosis by activating the PPARα and AMPK signaling pathways in hepatocytes. Int J Mol Med. 2015;35(3):803-809.
|